[HTML][HTML] Poor outcome of patients with COVID-19 after CAR T-cell therapy for B-cell malignancies: results of a multicenter study on behalf of the European Society for …
AM Spanjaart, P Ljungman, R de La Camara… - Leukemia, 2021 - nature.com
COVID-19 is posing a significant threat to health in vulnerable patients, such as
immunocompromised patients. For hematopoietic cell transplantation (HCT) recipients and …
immunocompromised patients. For hematopoietic cell transplantation (HCT) recipients and …
[HTML][HTML] Improved outcomes over time and higher mortality in CMV seropositive allogeneic stem cell transplantation patients with COVID-19; An infectious disease …
P Ljungman, G Tridello, JL Piñana, F Ciceri… - Frontiers in …, 2023 - frontiersin.org
Introduction COVID-19 has been associated with high morbidity and mortality in allogeneic
hematopoietic stem cell transplant (allo-HCT) recipients. Methods This study reports on 986 …
hematopoietic stem cell transplant (allo-HCT) recipients. Methods This study reports on 986 …
Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemia
C Šálek, F Folber, E Froňková… - European Journal of …, 2016 - Wiley Online Library
Objective To evaluate the prognostic power of minimal residual disease (MRD) monitored by
polymerase chain reaction at defined time points during early treatment in adult patients with …
polymerase chain reaction at defined time points during early treatment in adult patients with …
Autologous hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: still not out of fashion
M Doubek, F Folber, Z Koristek, Y Brychtova… - Annals of …, 2009 - Springer
The role of autologous hematopoietic stem cell transplantation (autoHSCT) in adult acute
lymphoblastic leukemia (ALL) is still unclear. We retrospectively analyzed the results of the …
lymphoblastic leukemia (ALL) is still unclear. We retrospectively analyzed the results of the …
[HTML][HTML] High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience
T Kabut, B Weinbergerová, F Folber… - Bone Marrow …, 2023 - nature.com
There is only limited data on cytomegalovirus (CMV) prophylaxis with high-dose (HD)
aciclovir after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We performed …
aciclovir after allogeneic hematopoietic stem cell transplantation (allo-HSCT). We performed …
[HTML][HTML] Performance of anti-CD19 chimeric antigen receptor T cells in genetically defined classes of chronic lymphocytic leukemia
V Mancikova, H Peschelova, V Kozlova… - … for ImmunoTherapy of …, 2020 - ncbi.nlm.nih.gov
Background While achieving prolonged remissions in other B cell-derived malignancies,
chimeric antigen receptor (CAR) T cells still underperform when injected into patients with …
chimeric antigen receptor (CAR) T cells still underperform when injected into patients with …
Genomic landscape of B-other acute lymphoblastic leukemia in an adult retrospective cohort with a focus on BCR-ABL1-like subtype
S Hrabovsky, Z Vrzalova, J Stika, H Jelinkova… - Acta …, 2021 - Taylor & Francis
Introduction BCR-ABL1-like acute lymphoblastic leukemia (ALL) is a high-risk disease with a
complex genomic background. Though extensively studied, data on the frequency and …
complex genomic background. Though extensively studied, data on the frequency and …
NOD/SCID IL2Rγ-null mouse xenograft model of human p53-mutated chronic lymphocytic leukemia and ATM-mutated mantle cell lymphoma using permanent cell …
J Verner, M Trbusek, J Chovancova… - Leukemia & …, 2015 - Taylor & Francis
Xenograft models represent a promising tool to study the pathogenesis of hematological
malignancies. To establish a reliable and appropriate in vivo model of aggressive human B …
malignancies. To establish a reliable and appropriate in vivo model of aggressive human B …
Comparison of real-time quantitative polymerase chain reaction and eight-color flow cytometry in assessment of minimal residual disease in adult acute lymphoblastic …
S Hrabovsky, F Folber, JM Horacek… - … Myeloma and Leukemia, 2018 - Elsevier
Background Minimal residual disease (MRD) is an important prognostic maker in acute
lymphoblastic leukemia (ALL). However, few data comparing the measurement of adult ALL …
lymphoblastic leukemia (ALL). However, few data comparing the measurement of adult ALL …
Outcomes of 167 healthy sibling donors after peripheral blood stem cell mobilization with G-CSF 16μg/kg/day: efficacy and safety.
M Krejci, A Janíková, F Folber, Z Král, J Mayer - Neoplasma, 2015 - europepmc.org
Mobilization of peripheral blood stem cells (PBSC) using the granulocyte colony-stimulating
factor (G-CSF) has enabled the collection even from older donors and those with …
factor (G-CSF) has enabled the collection even from older donors and those with …